5-122070068-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3

The NM_002317.7(LOX):​c.1232G>T​(p.Gly411Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

LOX
NM_002317.7 missense

Scores

3
11
5

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.74
Variant links:
Genes affected
LOX (HGNC:6664): (lysyl oxidase) This gene encodes a member of the lysyl oxidase family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate a regulatory propeptide and the mature enzyme. The copper-dependent amine oxidase activity of this enzyme functions in the crosslinking of collagens and elastin, while the propeptide may play a role in tumor suppression. In addition, defects in this gene have been linked with predisposition to thoracic aortic aneurysms and dissections. [provided by RefSeq, Jul 2016]
SRFBP1 (HGNC:26333): (serum response factor binding protein 1) Enables RNA binding activity. Predicted to be involved in maturation of SSU-rRNA. Predicted to be located in perinuclear region of cytoplasm. Predicted to be part of 90S preribosome. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.806

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LOXNM_002317.7 linkc.1232G>T p.Gly411Val missense_variant 6/7 ENST00000231004.5 NP_002308.2 P28300D0PNI2
LOXNM_001178102.2 linkc.542G>T p.Gly181Val missense_variant 5/6 NP_001171573.1 B7ZAJ4
LOXNM_001317073.1 linkc.341G>T p.Gly114Val missense_variant 5/6 NP_001304002.1 B0AZT2
SRFBP1XM_017009111.3 linkc.1106-5247C>A intron_variant XP_016864600.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LOXENST00000231004.5 linkc.1232G>T p.Gly411Val missense_variant 6/71 NM_002317.7 ENSP00000231004.4 P28300

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 27, 2021The p.G411V variant (also known as c.1232G>T), located in coding exon 6 of the LOX gene, results from a G to T substitution at nucleotide position 1232. The glycine at codon 411 is replaced by valine, an amino acid with dissimilar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.74
BayesDel_addAF
Uncertain
0.090
D
BayesDel_noAF
Benign
-0.11
CADD
Pathogenic
29
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.46
T;T
Eigen
Uncertain
0.66
Eigen_PC
Uncertain
0.65
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.91
.;D
M_CAP
Benign
0.039
D
MetaRNN
Pathogenic
0.81
D;D
MetaSVM
Benign
-0.81
T
MutationAssessor
Uncertain
2.6
M;M
PrimateAI
Uncertain
0.78
T
PROVEAN
Pathogenic
-5.2
D;.
REVEL
Benign
0.27
Sift
Uncertain
0.0040
D;.
Sift4G
Uncertain
0.011
D;.
Polyphen
0.99
D;D
Vest4
0.83
MutPred
0.68
Loss of glycosylation at S410 (P = 0.025);Loss of glycosylation at S410 (P = 0.025);
MVP
0.35
MPC
1.6
ClinPred
0.99
D
GERP RS
5.3
Varity_R
0.81
gMVP
0.65

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr5-121405763; API